OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 44 citing articles:

TRAF2 promotes M2-polarized tumor-associated macrophage infiltration, angiogenesis and cancer progression by inhibiting autophagy in clear cell renal cell carcinoma
Yawei Xu, Lei Li, Wuping Yang, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 34

Wnt signaling: Modulating tumor-associated macrophages and related immunotherapeutic insights
Yimeng Yuan, Dapeng Wu, Yifan Hou, et al.
Biochemical Pharmacology (2024) Vol. 223, pp. 116154-116154
Open Access | Times Cited: 14

Bioinformatics Analysis of coagulation-related genes in lung adenocarcinoma: unveiling prognostic indicators and treatment pathways
Minliang Huang, Zhanghao Huang, Shichen Miao, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1

Harnessing Immunotherapy for Hepatocellular Carcinoma: Principles and Emerging Promises
Hossein Miri, Payman Rahimzadeh, Mehrdad Hashemi, et al.
Pathology - Research and Practice (2025), pp. 155928-155928
Closed Access | Times Cited: 1

High LGALS3 expression induced by HCP5/hsa-miR-27b-3p correlates with poor prognosis and tumor immune infiltration in hepatocellular carcinoma
Yinghui Ren, Yongmei Qian, Qicheng Zhang, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6

Single-cell RNA sequencing reveals the evolution of the immune landscape during perihematomal edema progression after intracerebral hemorrhage
Peng Zhang, Cong Gao, Qiang Guo, et al.
Journal of Neuroinflammation (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 5

Immune landscape of hepatocellular carcinoma tumor microenvironment identifies a prognostic relevant model
Hongru Cao, Ping Huang, Jiawei Qiu, et al.
Heliyon (2024) Vol. 10, Iss. 3, pp. e24861-e24861
Open Access | Times Cited: 4

Exosomal ncRNAs: Multifunctional contributors to the immunosuppressive tumor microenvironment of hepatocellular carcinoma
Qi Huang, Xin Zhong, Jing Li, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116409-116409
Open Access | Times Cited: 4

Construction and significance of a breast cancer prognostic model based on cuproptosis-related genotyping and lncRNAs
Lu Sun, Xinxu Chen, Fei Li, et al.
Journal of the Formosan Medical Association (2024)
Open Access | Times Cited: 4

OGA mutant aberrantly hydrolyzes O-GlcNAc modification from PDLIM7 to modulate p53 and cytoskeleton in promoting cancer cell malignancy
Chia‐Wei Hu, Ao Wang, Dacheng Fan, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 24
Closed Access | Times Cited: 3

Machine learning-based identification of biomarkers and drugs in immunologically cold and hot pancreatic adenocarcinomas
Jia Ge, Juan Ge, Gu Tang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3

Biomarkers predicting the efficacy of immune checkpoint inhibitors in hepatocellular carcinoma
Ran Qin, Tianqiang Jin, Feng Xu
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8

m6A-Related Angiogenic Genes to Construct Prognostic Signature, Reveal Immune and Oxidative Stress Landscape, and Screen Drugs in Hepatocellular Carcinoma
Xiaodong Qu, Luyao Zhang, Songbo Li, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-24
Open Access | Times Cited: 14

KLF2 is a clinical diagnostic and treatment biomarker of breast cancer
Ya-Zhao Li, Juan Xie, Ruiqi Wang, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 7

Targeting the Heterogeneous Tumour-Associated Macrophages in Hepatocellular Carcinoma
Aloña Agirre‐Lizaso, Maider Huici-Izagirre, Josu Urretabizkaia-Garmendia, et al.
Cancers (2023) Vol. 15, Iss. 20, pp. 4977-4977
Open Access | Times Cited: 7

Inflammation-related prognostic markers in resected hepatocellular carcinoma
Fabio Giannone, Nevena Slovic, Patrick Pessaux, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 7

Unleashing the potential of gene signatures as prognostic and predictive tools: A step closer to personalized medicine in hepatocellular carcinoma (HCC)
Atieh Pourbagheri‐Sigaroodi, Fatemeh Fallah, Davood Bashash, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 1
Closed Access | Times Cited: 2

High-motility pro-tumorigenic monocytes drive macrophage enrichment in the tumor microenvironment
Wenxuan Du, Bryan Zhou, André Forjaz, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2

Cellular senescence-related genes: predicting prognosis in hepatocellular carcinoma
Weiwei Yuan, Yuanmin Xu, Zhiheng Wu, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 5

Page 1 - Next Page

Scroll to top